Cholesterol, lipids, and statins.
In conclusion, our targets for LDL-C are changing. Right now, the goal is less than 100 mg/dL, with an optional goal of less than 70 in very-high-risk individuals. To achieve these targets, we have available more effective statins as well as more effective combination therapies. An exciting area for potentially even greater reduction in events is raising HDL-C in conjunction with aggressive efforts to lower LDL-C.
Ballantyne
Christie M
CM
Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Texas, USA. cmb@bcm.tmc.edu
D008076:Cholesterol, HDL / Q000097:blood* / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors